| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/19/2009 | WO2009022235A2 Variants of prolactin as antagonists of its receptor |
| 02/19/2009 | WO2009022162A1 Bacillus with inactivated or downregulated htra and/or htrb |
| 02/19/2009 | WO2009022156A2 Peptides for desensibilization against allergens |
| 02/19/2009 | WO2009022155A2 Peptide with reduced dimer formation |
| 02/19/2009 | WO2009022154A2 Peptide with multiple epitopes |
| 02/19/2009 | WO2009022119A1 Murine endometriosis modelled by k-ras activation of menstruating endometrium |
| 02/19/2009 | WO2009022013A1 Insulin analogues with an acyl and aklylene glycol moiety |
| 02/19/2009 | WO2009022006A1 Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids |
| 02/19/2009 | WO2009022005A1 Insulin analogues with an acyl and alkylene glycol moiety |
| 02/19/2009 | WO2009021971A2 Novel targets and compounds for therapeutic intervention of hiv infection |
| 02/19/2009 | WO2009021956A2 Rapid acting insulin analogues |
| 02/19/2009 | WO2009021955A1 Rapid acting insulin analogues |
| 02/19/2009 | WO2009021468A1 Cell-penetrating peptides and use thereof bonded to biomolecules having therapeutic action |
| 02/19/2009 | WO2009021448A1 A plant height regulatory gene and uses thereof |
| 02/19/2009 | WO2009021289A1 Potassium channel inhibitors |
| 02/19/2009 | WO2009002480A3 Acyl transferase having altered substrate specificity |
| 02/19/2009 | WO2009002198A3 Expression cassette, t-dna molecule, plant expression vector, transgenic plant cell as well as their use in the manufacturing of a vaccine |
| 02/19/2009 | WO2008155363A3 Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof |
| 02/19/2009 | WO2008152252A3 Rumc peptides with antimicrobial activity |
| 02/19/2009 | WO2008145401A3 Mutated parvovirus structural proteins as vaccines |
| 02/19/2009 | WO2008142517A3 Synthetic peptide having anti-inflammatory and anti-microbic properties |
| 02/19/2009 | WO2008139238A3 Use of the augmenter of liver regeneration protein as an apoptosis regulator |
| 02/19/2009 | WO2008133908A3 Suspension formulations of insulinotropic peptides and uses thereof |
| 02/19/2009 | WO2008128526A9 Use of egfl7 for stem cell modulation |
| 02/19/2009 | WO2008125667A3 Screening for bone anabolic factors |
| 02/19/2009 | WO2008101671A9 Il-4 fc fusion proteins |
| 02/19/2009 | WO2008101160A3 Htra1-pdz and htra3-pdz modulators |
| 02/19/2009 | WO2008088422A3 Toxin peptide therapeutic agents |
| 02/19/2009 | WO2008073615A4 N-glycosylation mutant of melanoma differentiation associated gene-7 |
| 02/19/2009 | US20090049574 Use in altering root development, screening for herbicides; may enhance food production, especially in arid climates |
| 02/19/2009 | US20090049568 Method for preventing dehiscence and altering plant lignification |
| 02/19/2009 | US20090048431 Multivalent clostridial toxins |
| 02/19/2009 | US20090048428 inclusion body tags; Expression of the fusion peptide in a host cell results in a product that is insoluble and contained within inclusion bodies in the cell and/or cell lysate |
| 02/19/2009 | US20090048324 Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules |
| 02/19/2009 | US20090048175 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 02/19/2009 | US20090048171 Treatment of viral infections |
| 02/19/2009 | US20090048170 Target for anti-angiogenesis therapy |
| 02/19/2009 | US20090048169 Identification of Crmp4 as a Convergent Regulator of Axon Outgrowth Inhibition |
| 02/19/2009 | US20090048168 Inhibitors of bcl-2 |
| 02/19/2009 | US20090048166 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production; anemia; genetic discorder; blood disorders; erythropoietin receptor agonists |
| 02/19/2009 | US20090048164 Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same |
| 02/19/2009 | US20090048163 Nucleic acid and protein sequences of asporins |
| 02/19/2009 | US20090048161 Cytokine receptor modulators and uses thereof |
| 02/19/2009 | US20090048160 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (BPI)-derived peptides against Gram-negative bacterial mastitis isolates |
| 02/19/2009 | US20090048148 Compositions and methods for therapeutic use |
| 02/19/2009 | US20090048115 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047737 Human LY6-Big Molecules and Methods of Use |
| 02/19/2009 | US20090047736 Human T1R2 nucleic acid sequences and polypeptides |
| 02/19/2009 | US20090047735 Antibodies Against Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 02/19/2009 | US20090047706 Process for producing dipeptides |
| 02/19/2009 | US20090047701 Method for screening antifungal agents |
| 02/19/2009 | US20090047671 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 02/19/2009 | US20090047668 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 02/19/2009 | US20090047654 Polymer affinity matrix, a method for the production and use thereof |
| 02/19/2009 | US20090047381 Ammonia transporter gene and use thereof |
| 02/19/2009 | US20090047360 Bone morphogenic protein binding peptide |
| 02/19/2009 | US20090047339 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/19/2009 | US20090047303 Method for improving the immunogenicity of plasmodium antigens |
| 02/19/2009 | US20090047302 Chimaeric Human Papillomavirus 16 L1 Virus Like Particles and a Method for Preparing the Particles |
| 02/19/2009 | US20090047300 Blood-brain barrier epitopes and uses thereof |
| 02/19/2009 | US20090047287 Modulation of bone formation |
| 02/19/2009 | US20090047286 H2n3 influenza a viruses and methods of use |
| 02/19/2009 | US20090047284 Methods and compositions for PDGF-C activation and inhibition |
| 02/19/2009 | US20090047283 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/19/2009 | US20090047282 Prophylactic/Therapeutic Agent for Cancer |
| 02/19/2009 | US20090047275 Modulating calvarial osteoblast differentiation; fracture repair |
| 02/19/2009 | US20090047274 Diagnostic and therapeutic target cdc2l6 proteins for neurodegenerative diseases |
| 02/19/2009 | US20090047251 Conjugates of hydroxyalkyl starch and a protein |
| 02/19/2009 | US20090047241 Il-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation |
| 02/19/2009 | US20090047218 Method for producing albumin conjugates comprising an X-ray contrast medium as the active substance |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | CA2700923A1 Novel targets and compounds for therapeutic intervention of hiv infection |
| 02/19/2009 | CA2697265A1 Method of treating autoimmune disease with mesenchymal stem cells |
| 02/19/2009 | CA2696563A1 Peptides for vaccine |
| 02/19/2009 | CA2696478A1 Protein-polymer conjugates |
| 02/19/2009 | CA2696360A1 Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof |
| 02/19/2009 | CA2696047A1 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 02/19/2009 | CA2696011A1 Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| 02/19/2009 | CA2695999A1 Kappa-carrageenase and kappa-carrageenase-containing compositions |
| 02/19/2009 | CA2695971A1 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 02/19/2009 | CA2695970A1 Insulin analogues with an acyl and aklylene glycol moiety |
| 02/19/2009 | CA2695929A1 A plant height regulatory gene and uses thereof |
| 02/19/2009 | CA2695374A1 Compositions and methods for modifying properties of biologically active polypeptides |
| 02/19/2009 | CA2694735A1 Cell-penetrating peptides and use thereof bonded to biomolecules with therapeutic action |
| 02/19/2009 | CA2684873A1 Anti-bacterial drug targeting of genome maintenance interfaces |
| 02/19/2009 | CA2683748A1 Mutants of cholesterol-dependent cytolysins and uses thereof |
| 02/18/2009 | EP2025757A2 Polymeric immunoglobulin receptor-mediated gene transfer |
| 02/18/2009 | EP2025755A1 Research method for promoters in micro-organisms like rhodococcus |
| 02/18/2009 | EP2025754A2 Moraxella (Branhamella) catarrhalis antigens |
| 02/18/2009 | EP2025753A2 Phagemid for screening antibodies |
| 02/18/2009 | EP2025750A1 Novel targets and compounds for therapeutic intervention of HIV infection |
| 02/18/2009 | EP2025684A1 Glucagon analogues |
| 02/18/2009 | EP2025683A1 Variants of prolactin as antagonists of its receptor |
| 02/18/2009 | EP2025682A2 Human endokine alpha |
| 02/18/2009 | EP2025345A1 KIM-1 antagonists and use to modulate immune system |
| 02/18/2009 | EP2024538A2 Compositions for and methods of identifying antigens |
| 02/18/2009 | EP2024500A1 Gene family (lbfl313) associated with pancreatic cancer |
| 02/18/2009 | EP2024497A2 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis |
| 02/18/2009 | EP2024391A2 Crystal structure of crig and c3b: crig complex |